MRI as a biomarker for mild neonatal encephalopathy

Research output: Contribution to journalArticlepeer-review

Abstract

Historically, there has been limited neuro-imaging data acquired on infants with mild neonatal encephalopathy (NE). This likely reflects the traditional assumption that these infants had a universally good prognosis. As new evidence has emerged challenging this assumption, there has been a renewed interest in the neuro-imaging findings of these infants. To date, magnetic resonance imaging (MRI) studies in infants with mild NE have demonstrated abnormalities in 20–40% of cases suggestive that the injury occurs during the peripartum period with a predominant watershed pattern of injury. The severity of the injury on MRI in infants with mild NE varies, but includes patterns of injury that have been associated with long-term neuro-developmental impairment.

Original languageEnglish
Pages (from-to)75-79
Number of pages5
JournalEarly Human Development
Volume120
DOIs
Publication statusPublished - May 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Biomarker
  • Hypoxic ischemic encephalopathy
  • Magnetic resonance imaging
  • Mild neonatal encephalopathy
  • Perinatal asphyxia

Fingerprint

Dive into the research topics of 'MRI as a biomarker for mild neonatal encephalopathy'. Together they form a unique fingerprint.

Cite this